• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

小干扰RNA介导的血管内皮生长因子-A、血管内皮生长因子-C和血管内皮生长因子受体-3的敲低可抑制小鼠膀胱癌在体内的生长和转移。

siRNA-mediated knockdown of VEGF-A, VEGF-C and VEGFR-3 suppresses the growth and metastasis of mouse bladder carcinoma in vivo.

作者信息

Wang Feng, Li Hui-Ming, Wang Hui-Ping, Ma Jia-Lie, Chen Xia-Fang, Wei Fang, Yi Miao-Ying, Huang Qian

机构信息

Experimental Center, First People's Hospital, Medical School, Shanghai Jiaotong University, Shanghai 200080, P.R. China.

出版信息

Exp Ther Med. 2010 Sep;1(5):899-904. doi: 10.3892/etm.2010.113. Epub 2010 Jul 12.

DOI:10.3892/etm.2010.113
PMID:22993616
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3445895/
Abstract

The growth of solid tumors is highly dependent on the formation of new blood and/or lymph vessels. Furthermore, metastases often disperse via newly formed blood or lymphatic vessels within the tumor, particularly in the case of epithelium-derived tumors. Since vascular endothelial growth factor (VEGF) signaling plays a vital role in angiogenesis and lymphangiogenesis, we used the small interfering RNA (siRNA) approach to selectively down-regulate VEGF-A, VEGF-C or VEGF receptor 3 (VEGFR-3) expression in bladder transitional carcinoma cells derived from T739 mice in an attempt to suppress tumor growth and metastasis in vivo. The synthetic siRNA was introduced into the tumor tissues by in vivo electroporation. The knockdown of VEGF-A, VEGF-C and VEGFR-3 expression significantly delayed tumor growth and reduced tumor metastasis compared to the negative controls. Thus, electroporation-mediated siRNA delivery to block the VEGF signaling pathway may provide a novel approach for the treatment or prevention of solid tumor growth and metastasis.

摘要

实体瘤的生长高度依赖于新血管和/或淋巴管的形成。此外,转移灶通常通过肿瘤内新形成的血管或淋巴管扩散,上皮来源的肿瘤尤其如此。由于血管内皮生长因子(VEGF)信号通路在血管生成和淋巴管生成中起着至关重要的作用,我们使用小干扰RNA(siRNA)方法选择性下调源自T739小鼠的膀胱移行癌细胞中VEGF-A、VEGF-C或VEGF受体3(VEGFR-3)的表达,试图在体内抑制肿瘤生长和转移。通过体内电穿孔将合成的siRNA导入肿瘤组织。与阴性对照相比,VEGF-A、VEGF-C和VEGFR-3表达的敲低显著延迟了肿瘤生长并减少了肿瘤转移。因此,电穿孔介导的siRNA递送以阻断VEGF信号通路可能为实体瘤生长和转移的治疗或预防提供一种新方法。

相似文献

1
siRNA-mediated knockdown of VEGF-A, VEGF-C and VEGFR-3 suppresses the growth and metastasis of mouse bladder carcinoma in vivo.小干扰RNA介导的血管内皮生长因子-A、血管内皮生长因子-C和血管内皮生长因子受体-3的敲低可抑制小鼠膀胱癌在体内的生长和转移。
Exp Ther Med. 2010 Sep;1(5):899-904. doi: 10.3892/etm.2010.113. Epub 2010 Jul 12.
2
Suppression of tumor lymphangiogenesis and lymph node metastasis by blocking vascular endothelial growth factor receptor 3 signaling.通过阻断血管内皮生长因子受体3信号通路抑制肿瘤淋巴管生成和淋巴结转移
J Natl Cancer Inst. 2002 Jun 5;94(11):819-25. doi: 10.1093/jnci/94.11.819.
3
Suppression of lymphangiogenesis by soluble vascular endothelial growth factor receptor-2 in a mouse lung cancer model.可溶性血管内皮生长因子受体-2在小鼠肺癌模型中对淋巴管生成的抑制作用
Biomed Pharmacother. 2016 Dec;84:660-665. doi: 10.1016/j.biopha.2016.09.083. Epub 2016 Sep 30.
4
Soluble vascular endothelial growth factor receptor-3 suppresses lymphangiogenesis and lymphatic metastasis in bladder cancer.可溶性血管内皮生长因子受体-3 抑制膀胱癌中的淋巴管生成和淋巴转移。
Mol Cancer. 2011 Apr 11;10:36. doi: 10.1186/1476-4598-10-36.
5
Sunitinib inhibits lymphatic endothelial cell functions and lymph node metastasis in a breast cancer model through inhibition of vascular endothelial growth factor receptor 3.舒尼替尼通过抑制血管内皮生长因子受体 3 抑制乳腺癌模型中的淋巴管内皮细胞功能和淋巴结转移。
Breast Cancer Res. 2011 Jun 21;13(3):R66. doi: 10.1186/bcr2903.
6
Lentivirus-mediated small interfering RNA targeting VEGF-C inhibited tumor lymphangiogenesis and growth in breast carcinoma.慢病毒介导的靶向血管内皮生长因子C的小干扰RNA抑制乳腺癌肿瘤淋巴管生成和生长。
Anat Rec (Hoboken). 2009 May;292(5):633-9. doi: 10.1002/ar.20893.
7
Qingjie Fuzheng Granule suppresses lymphangiogenesis in colorectal cancer via the VEGF-C/VEGFR-3 dependent PI3K/AKT pathway.清解扶正颗粒通过 VEGF-C/VEGFR-3 依赖的 PI3K/AKT 通路抑制结直肠癌淋巴管生成。
Biomed Pharmacother. 2021 May;137:111331. doi: 10.1016/j.biopha.2021.111331. Epub 2021 Feb 9.
8
Vascular endothelial growth factor-a promotes peritumoral lymphangiogenesis and lymphatic metastasis.血管内皮生长因子-a促进肿瘤周围淋巴管生成和淋巴转移。
Cancer Res. 2005 Oct 15;65(20):9261-8. doi: 10.1158/0008-5472.CAN-04-2345.
9
3-O-Acetyloleanolic acid inhibits VEGF-A-induced lymphangiogenesis and lymph node metastasis in an oral cancer sentinel lymph node animal model.3-O-乙酰齐墩果酸抑制血管内皮生长因子-A 诱导的口腔癌前哨淋巴结动物模型中的淋巴管生成和淋巴结转移。
BMC Cancer. 2018 Jul 5;18(1):714. doi: 10.1186/s12885-018-4630-0.
10
A potential small-molecule synthetic antilymphangiogenic agent norcantharidin inhibits tumor growth and lymphangiogenesis of human colonic adenocarcinomas through blocking VEGF-A,-C,-D/VEGFR-2,-3 "multi-points priming" mechanisms in vitro and in vivo.一种潜在的小分子合成抗淋巴管生成剂去甲斑蝥素通过在体外和体内阻断VEGF-A、-C、-D/VEGFR-2、-3“多点启动”机制来抑制人结肠腺癌的肿瘤生长和淋巴管生成。
BMC Cancer. 2015 Jul 19;15:527. doi: 10.1186/s12885-015-1521-5.

引用本文的文献

1
Sulfated polysaccharide of ink targets Akt and overcomes resistance to the FGFR inhibitor AZD4547 in bladder cancer.墨汁中的硫酸化多糖靶向Akt并克服膀胱癌对FGFR抑制剂AZD4547的耐药性。
Aging (Albany NY). 2019 Sep 23;11(18):7780-7795. doi: 10.18632/aging.102286.
2
Intrabody targeting vascular endothelial growth factor receptor-2 mediates downregulation of surface localization.靶向血管内皮生长因子受体-2的胞内抗体介导表面定位下调。
Cancer Gene Ther. 2017 Jan;24(1):33-37. doi: 10.1038/cgt.2016.76. Epub 2016 Dec 16.
3
Targeted therapies in bladder cancer: an overview of in vivo research.膀胱癌的靶向治疗:体内研究概述。
Nat Rev Urol. 2015 Dec;12(12):681-94. doi: 10.1038/nrurol.2015.231. Epub 2015 Sep 22.
4
AEG-1 Promotes Metastasis Through Downstream AKR1C2 and NF1 in Liver Cancer.AEG-1通过下游的AKR1C2和NF1促进肝癌转移。
Oncol Res. 2014;22(4):203-211. doi: 10.3727/096504015X14386062091352.

本文引用的文献

1
Lymphatic vessel density and function in experimental bladder cancer.实验性膀胱癌中的淋巴管密度与功能
BMC Cancer. 2007 Nov 29;7:219. doi: 10.1186/1471-2407-7-219.
2
RNA interference (RNAi)-mediated vascular endothelial growth factor-C (VEGF-C) reduction interferes with lymphangiogenesis and enhances epirubicin sensitivity of breast cancer cells.RNA干扰(RNAi)介导的血管内皮生长因子C(VEGF-C)减少会干扰淋巴管生成并增强乳腺癌细胞对表柔比星的敏感性。
Mol Cell Biochem. 2008 Jan;308(1-2):161-8. doi: 10.1007/s11010-007-9624-1. Epub 2007 Oct 16.
3
VEGF-targeted RNA interference suppresses angiogenesis and tumor growth of retinoblastoma.血管内皮生长因子靶向RNA干扰抑制视网膜母细胞瘤的血管生成和肿瘤生长。
Ophthalmic Res. 2007;39(2):108-15. doi: 10.1159/000099247. Epub 2007 Feb 2.
4
Evaluation of the vascular endothelial growth factor (VEGF)-C role in urothelial carcinomas of the bladder.
Anticancer Res. 2006 Sep-Oct;26(5A):3567-71.
5
Preparing the "soil": the primary tumor induces vasculature reorganization in the sentinel lymph node before the arrival of metastatic cancer cells.准备“土壤”:在转移性癌细胞到达之前,原发性肿瘤会诱导前哨淋巴结中的血管系统重组。
Cancer Res. 2006 Nov 1;66(21):10365-76. doi: 10.1158/0008-5472.CAN-06-2977. Epub 2006 Oct 23.
6
Vascular endothelial growth factor-C expression in bladder transitional cell cancer and its relationship to lymph node metastasis.血管内皮生长因子-C在膀胱移行细胞癌中的表达及其与淋巴结转移的关系。
BJU Int. 2006 Nov;98(5):1090-3. doi: 10.1111/j.1464-410X.2006.06446.x.
7
siRNA-based approaches in cancer therapy.基于小干扰RNA的癌症治疗方法。
Cancer Gene Ther. 2006 Sep;13(9):819-29. doi: 10.1038/sj.cgt.7700931. Epub 2006 Jan 20.
8
RNA interference and potential therapeutic applications of short interfering RNAs.RNA干扰及小干扰RNA的潜在治疗应用
Cancer Gene Ther. 2005 Oct;12(10):787-95. doi: 10.1038/sj.cgt.7700857.
9
A small interfering RNA targeting vascular endothelial growth factor inhibits Ewing's sarcoma growth in a xenograft mouse model.一种靶向血管内皮生长因子的小干扰RNA在异种移植小鼠模型中抑制尤因肉瘤的生长。
Clin Cancer Res. 2005 Apr 1;11(7):2662-9. doi: 10.1158/1078-0432.CCR-04-1206.
10
RNA interference and chemically modified small interfering RNAs.RNA干扰与化学修饰的小干扰RNA
Curr Opin Chem Biol. 2004 Dec;8(6):570-9. doi: 10.1016/j.cbpa.2004.10.007.